Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
ST

STAA

Market Closed

STAAR Surgical Company

NASDAQHealthcareMedical - Instruments & Supplies
US
921 employees
CEO: Warren Foust
Founded: 1992
$21.73
+$0.00(+NaN%)
Market Cap
1.09B
Beta
1.18
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: STAA trades 36.8% above a high-confidence fair value of $13.73, with DCF analysis indicating negative intrinsic value. Strong liquidity and leverage contrast with zero profitability and efficiency, highlighting financial stress despite stable downside risk. Valuation metrics signal potential overvaluation amid weak operational performance.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore STAA

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

STAA in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →